000 | 01414 a2200361 4500 | ||
---|---|---|---|
005 | 20250517203817.0 | ||
264 | 0 | _c20180910 | |
008 | 201809s 0 0 eng d | ||
022 | _a1791-244X | ||
024 | 7 |
_a10.3892/ijmm.2018.3531 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHua, Fu | |
245 | 0 | 0 |
_aDaidzein exerts anticancer activity towards SKOV3 human ovarian cancer cells by inducing apoptosis and cell cycle arrest, and inhibiting the Raf/MEK/ERK cascade. _h[electronic resource] |
260 |
_bInternational journal of molecular medicine _cJun 2018 |
||
300 |
_a3485-3492 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Retracted Publication | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoflavones _xpharmacology |
650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
650 | 0 | 4 | _aOvarian Neoplasms |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-raf _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
700 | 1 | _aLi, Chang-Hua | |
700 | 1 | _aChen, Xiao-Gang | |
700 | 1 | _aLiu, Xiao-Ping | |
773 | 0 |
_tInternational journal of molecular medicine _gvol. 41 _gno. 6 _gp. 3485-3492 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3892/ijmm.2018.3531 _zAvailable from publisher's website |
999 |
_c28153234 _d28153234 |